WAM
FSTX

Weiss Asset Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Weiss Asset Management’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-548,189
Closed -$3.46M – 643
2022
Q4 		$3.46M Buy
+548,189
New +$3.03M 0.14% 182

Weiss Asset Management's FSTX Position: Q1 2023 in Review

Weiss Asset Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 548,189 shares — an estimated $3.46M sold.

Weiss Asset Management first reported a position in FSTX in Q4 2022 and held it in 1 quarter. The position peaked at $3.46M in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

  • Weiss Asset Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Weiss Asset Management sold 548,189 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $3.46M.
  • Weiss Asset Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Weiss Asset Management's F-star Therapeutics, Inc. Common Stock position peaked at $3.46M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Weiss Asset Management's 13F filing for Q1 2023, filed 10 May 2023.